Unlearn, a leading AI company, has announced the appointment of Jack McGovern as CFO and Marco Calderon as Chief of Staff to the CEO, marking a significant milestone in the company’s growth. Both bring substantial experience, with McGovern’s strategic financial leadership and Calderon’s contribution to building a strong company culture set to advance Unlearn’s mission of advancing AI to eliminate trial and error in medicine.

SAN FRANCISCO, July 11, 2023 /PRNewswire-PRWeb/ — Unlearn, a pioneering company at the forefront of artificial intelligence (AI) in medicine, is pleased to announce the addition of two strategic leaders to its team: Jack McGovern as Chief Financial Officer (CFO) and Marco Calderon as Chief of Staff to Unlearn’s CEO and Founder, Charles Fisher.

McGovern brings a wealth of experience as a corporate finance executive with a strong background in public and venture-backed companies, particularly in the tech and SaaS-based business models. McGovern’s expertise in managing public offerings, securing financing, and scaling high-performing teams will be instrumental in Unlearn’s continued growth and financial stability.

Joining Mcgovern is Calderon, assuming the critical role of Chief of Staff to the CEO, where he will support the strategic initiatives of Unlearn and bring valuable insights and leadership to the team. An early employee of Robinhood, he spent the past six years helping the company scale through hypergrowth as a founding member of Robinhood’s Product Operations team and Chief of Staff to one of the company co-founders. Prior to Robinhood, Calderon spent nearly five years at Avascent (now Oliver Wyman) in the analytics department of their defense and aerospace practice.

The addition of McGovern and Calderon to Unlearn’s team represents a significant milestone in the company’s growth trajectory. “We are thrilled to welcome Jack and Marco to the Unlearn team,” said Fisher. “McGovern’s strategic financial guidance and proven leadership, combined with Calderon’s passion for building a positive company culture, will advance Unlearn’s mission to eliminate trial and error in medicine through AI, fostering collaboration and driving impactful solutions for the benefit of patients worldwide.”

With the combined expertise of McGovern and Calderon, Unlearn is well-positioned to continue its groundbreaking work driving innovation in the field of AI.

About Unlearn

Unlearn is a San Francisco-based technology company pioneering generative machine learning methods to eliminate trial and error in medicine. Unlearn’s technology using patient digital twins is regulatory-qualified and used by leading global pharmaceutical companies to run AI-powered clinical trials that reach full enrollment faster and bring new treatments to patients sooner.

Pull Quote

“McGovern’s strategic financial guidance and proven leadership, combined with Calderon’s passion for building a positive company culture, will advance Unlearn’s mission to eliminate trial and error in medicine through AI.” – Charles Fisher, CEO and Founder of Unlearn.

Media Contact

Heather D’Angelo, Unlearn, 1 9175233263, [email protected], unlearn.ai

SOURCE Unlearn